Meta-Analysis

. 2022 Sep 2;31(9):1769-1779.

doi: 10.1158/1055-9965.EPI-22-0123.

Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk

Chiara Grasso¹, Maja Popovic¹, Elena Isaevska¹, Fulvio Lazzarato¹, Valentina Fiano¹, Daniela Zugna¹, John Pluta², Benita Weathers², Kurt D'Andrea², Kristian Almstrup^{3

4}, Lynn Anson-Cartwright⁵, D Timothy Bishop⁶, Stephen J Chanock⁷, Chu Chen^{8

9}, Victoria K Cortessis¹⁰, Marlene D Dalgaard¹¹, Siamak Daneshmand¹², Alberto Ferlin¹³, Carlo Foresta¹³, Megan N Frone⁷, Marija Gamulin¹⁴, Jourik A Gietema¹⁵, Mark H Greene⁷, Tom Grotmol¹⁶, Robert J Hamilton⁵, Trine B Haugen¹⁷, Russ Hauser¹⁸, Robert Karlsson¹⁹, Lambertus A Kiemeney²⁰, Davor Lessel²¹, Patrizia Lista²², Ragnhild A Lothe^{23

24}, Chey Loveday²⁵, Coby Meijer¹⁵, Kevin T Nead²⁶, Jérémie Nsengimana²⁷, Rolf I Skotheim^{23

28}, Clare Turnbull^{25

29}, David J Vaughn^{30

31}, Fredrik Wiklund¹⁹, Tongzhang Zheng³², Andrea Zitella³³, Stephen M Schwartz^{8

9}, Katherine A McGlynn⁷, Peter A Kanetsky³⁴, Katherine L Nathanson^{2

31}, Lorenzo Richiardi¹

Affiliations

¹ Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy.
² Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
³ Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
⁴ Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Surgery (Urology), University of Toronto and The Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
⁶ Department of Haematology and Immunology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
⁷ Division of Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
⁸ Program in Epidemiology, Fred Hutchinson Cancer Center, Seattle, Washington.
⁹ Department of Epidemiology, University of Washington, Seattle, Washington.
¹⁰ Department of Population and Public Health Sciences, and Obstetrics and Gynecology, Keck School of Medicine at the University of Southern California, Los Angeles, California.
¹¹ Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
¹² Department of Urology, Keck School of Medicine at the University of Southern California, Los Angeles, California.
¹³ Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.
¹⁴ Department of Oncology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
¹⁵ Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
¹⁶ Department of Research, Cancer Registry of Norway, Oslo, Norway.
¹⁷ Faculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.
¹⁸ Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
¹⁹ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
²⁰ Radboud University Medical Center, Nijmegen, the Netherlands.
²¹ Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
²² Division of Medical Oncology, AOU "Città della Salute e della Scienza di Torino", Turin, Italy.
²³ Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
²⁴ Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
²⁵ Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
²⁶ Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
²⁷ Biostatistics Research Group, Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.
²⁸ Department of Informatics, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
²⁹ Royal Marsden NHS Foundation Hospital, London, United Kingdom.
³⁰ Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
³¹ Abramson Cancer Center, Perelman School of Medicine, Philadelphia, Pennsylvania.
³² Department of Epidemiology, Brown School of Public Health, Brown University, Providence, Rhode Island.
³³ Division of Urology, Department of Surgical Science, AOU "Città della Salute e della Scienza di Torino", University of Turin, Turin, Italy.
³⁴ Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

PMID: 35700037
PMCID: PMC9444936
DOI: 10.1158/1055-9965.EPI-22-0123

Meta-Analysis

Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk

Chiara Grasso et al. Cancer Epidemiol Biomarkers Prev. 2022.

. 2022 Sep 2;31(9):1769-1779.

doi: 10.1158/1055-9965.EPI-22-0123.

Authors

Affiliations

¹ Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy.
² Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
³ Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
⁴ Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Surgery (Urology), University of Toronto and The Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
⁶ Department of Haematology and Immunology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
⁷ Division of Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
⁸ Program in Epidemiology, Fred Hutchinson Cancer Center, Seattle, Washington.
⁹ Department of Epidemiology, University of Washington, Seattle, Washington.
¹⁰ Department of Population and Public Health Sciences, and Obstetrics and Gynecology, Keck School of Medicine at the University of Southern California, Los Angeles, California.
¹¹ Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
¹² Department of Urology, Keck School of Medicine at the University of Southern California, Los Angeles, California.
¹³ Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.
¹⁴ Department of Oncology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
¹⁵ Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
¹⁶ Department of Research, Cancer Registry of Norway, Oslo, Norway.
¹⁷ Faculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.
¹⁸ Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
¹⁹ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
²⁰ Radboud University Medical Center, Nijmegen, the Netherlands.
²¹ Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
²² Division of Medical Oncology, AOU "Città della Salute e della Scienza di Torino", Turin, Italy.
²³ Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
²⁴ Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
²⁵ Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
²⁶ Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
²⁷ Biostatistics Research Group, Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.
²⁸ Department of Informatics, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
²⁹ Royal Marsden NHS Foundation Hospital, London, United Kingdom.
³⁰ Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
³¹ Abramson Cancer Center, Perelman School of Medicine, Philadelphia, Pennsylvania.
³² Department of Epidemiology, Brown School of Public Health, Brown University, Providence, Rhode Island.
³³ Division of Urology, Department of Surgical Science, AOU "Città della Salute e della Scienza di Torino", University of Turin, Turin, Italy.
³⁴ Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

PMID: 35700037
PMCID: PMC9444936
DOI: 10.1158/1055-9965.EPI-22-0123

Abstract

Background: Testicular germ cell tumors (TGCT), histologically classified as seminomas and nonseminomas, are believed to arise from primordial gonocytes, with the maturation process blocked when they are subjected to DNA methylation reprogramming. SNPs in DNA methylation machinery and folate-dependent one-carbon metabolism genes have been postulated to influence the proper establishment of DNA methylation.

Methods: In this pathway-focused investigation, we evaluated the association between 273 selected tag SNPs from 28 DNA methylation-related genes and TGCT risk. We carried out association analysis at individual SNP and gene-based level using summary statistics from the Genome Wide Association Study meta-analysis recently conducted by the international Testicular Cancer Consortium on 10,156 TGCT cases and 179,683 controls.

Results: In individual SNP analyses, seven SNPs, four mapping within MTHFR, were associated with TGCT risk after correction for multiple testing (q ≤ 0.05). Queries of public databases showed that three of these SNPs were associated with MTHFR changes in enzymatic activity (rs1801133) or expression level in testis tissue (rs12121543, rs1476413). Gene-based analyses revealed MTHFR (q = 8.4 × 10-4), methyl-CpG-binding protein 2 (MECP2; q = 2 × 10-3), and ZBTB4 (q = 0.03) as the top TGCT-associated genes. Stratifying by tumor histology, four MTHFR SNPs were associated with seminoma. In gene-based analysis MTHFR was associated with risk of seminoma (q = 2.8 × 10-4), but not with nonseminomatous tumors (q = 0.22).

Conclusions: Genetic variants within MTHFR, potentially having an impact on the DNA methylation pattern, are associated with TGCT risk.

Impact: This finding suggests that TGCT pathogenesis could be associated with the folate cycle status, and this relation could be partly due to hereditary factors.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors report no conflict of interest.

Figures

**Figure 1.**
Flow chart of the eight studies assembled by the Testicular Cancer Consortium. Cases and controls from these studies have been involved in the main analysis of the current work.

See this image and copyright information in PMC

References

1. Gurney JK, Florio AA, Znaor A, Ferlay J, Laversanne M, Sarfati D, et al. International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries. EurUrol 2019;76:615–23. - PMC - PubMed
1. Znaor A, Skakkebaek NE, Rajpert-De Meyts E, Laversanne M, Kuliš T, Gurney J, et al. Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing. Int J Cancer 2020;147:820–28. - PMC - PubMed
1. Shen H, Shih J, Hollern DP, Wang L, Bowlby R, Tickoo SK, et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep 2018;23:3392–406. - PMC - PubMed
1. Akan S, Ediz C, Tavukcu HH, Ozgun A, Yilmaz O. The clinical significance of seminoma component in testicular mixed germ cell tumour. Urol Int 2020;104:489–96. - PubMed
1. Baird DC, Meyers GJ, Hu JS. Testicular cancer: diagnosis and treatment. Am Fam Physician 2018;97:261–8. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Supplementary concepts

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk

Affiliations

Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Substances

Supplementary concepts

Grants and funding

LinkOut - more resources

Full Text Sources

Medical